Bradley Prechtl Explains the Importance of Dispelling Patient Misconceptions of Clinical Trials

October 31, 2019

I think there is a lot of confusion, especially in the patient community, about clinical research., explained Bradley Prechtl, MBA, chief executive officer of Florida Cancer Specialists and the American Oncology Network.

I think there is a lot of confusion, especially in the patient community, about clinical research, explained Bradley Prechtl, MBA, chief executive officer of Florida Cancer Specialists and the American Oncology Network.

Transcript

When offering clinical trials to patients, does this require dispelling misconceptions they might have about participating in a trial?

I think there is a lot of confusion, especially in the patient community, about clinical research. A lot of patients I think hear clinical research thinking they’re going to be some sort of guinea pig. They don’t know if it’s a real drug or a placebo or whatever the case may be. We’ve had so many patients that have been enrolled in clinical trials that were not progressing well with standard of care that they’ve had incredible outcomes. I think one of our goals is continuing to try and educate patients on what is clinical research and really dumbing it down because even people that are in healthcare, I think, often times have misconceptions about what clinical research really is.